VANI news

Latest 1 stories · newest Aug 6, 2026

VANI

Vivani completes dosing in 20-participant NPM-139 trial

Vivani Medical announced successful dosing of all SLIM-1 trial participants, evaluating its NPM-139 implant ahead of schedule. With data expected in 2026, this advance follows a recent partnership with Novo Nordisk.

Other Aug 6, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same VANI feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/VANI/newsSTART FREE